Spending of remuneration by subjects in non-treatment drug abuse research studies

American Journal of Drug and Alcohol Abuse

Volumn 32, Issue 4, 2006, Pages 527-540

  Kurlander, Jacob E ^a   Simon Dack, Stephanie L ^b   Gorelick, David A ^c  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Drug abuse; In kind; Motivation; Payment; Research; Subjects

Indexed keywords

CANNABIS DERIVATIVE; COCAINE;

ADULT; ARTICLE; DRUG ABUSE; ECONOMIC ASPECT; FEE; HUMAN; INCOME; INTELLIGENCE QUOTIENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; FEES AND CHARGES; HUMANS; INPATIENTS; MALE; MARIJUANA ABUSE; SUBSTANCE-RELATED DISORDERS; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 33845331329     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990600919427     Document Type: Article

References (16)

1. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. New England J Med 1999; 341(3): 198-203.
2. Dickert N, Emanuel E, Grady, C. Paying research subjects: An analysis of current policies. Ann Intern Med 2002; 136(5):368-373.
3. Fry CL, Ritter A, Baldwin S, Bowen KJ, Gardiner P, Holt T, Jenkinson R, Johnston J. Paying research participants: A study of current practices in Australia. J Med Ethics 2005; 31(9):542-547.
4. Grady, C. Money for research participation: Does it jeopardize informed consent? Amer J Bioethics 2001; 1(2):40-44.
5. Grady, C. Payment of clinical research subjects. J Clin Invest 2005; 115(7):1681-1687.
6. Russell ML, Moralejo DG, Burgess ED. Paying research subjects: Participants' perspectives. J Med Ethics 2000; 26(2):126-130.
7. Tishler CL, Bartholomae S. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. J Clin Pharmacol 2002; 42:363-373.
8. McCrady BS, Bux Jr. DA. Ethical issues in informed consent with substance abusers. J Consult Clin Psychol 1999; 67(2):186-193.
9. Amass L, Bickel WK, Crean JP, Higgins ST, Badger GJ. Preferences for clinic privileges, retail items, and social activities in an outpatient treatment program. Journal of Substance Abuse Treatment 1996; 13:43-49.
10. Rothfleisch J, Ronith E, Rhoades H, Schmitz J. Use of monetary reinforcers by cocaine-dependent outpatients. Journal of Substance Abuse Treatment 1999; 17:229-236.
11. Deren S, Stephens R, Davis WR, Feucht TE, Tortu S. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Reports 1994; 109(4):548-554.
12. Gorelick DA, Pickens R, Bonkovsky F. Clinical research in substance abuse: Human subjects issues. In Ethics in Psychiatric Research: A Resource Manual for Human Subject Protection. Pincus HA, Lieberman JA, Ferris S, eds. Washington, D.C.: American Psychiatric Press, 1999; 177-218.
13. Festinger DS, Marlowe DB, Croft JR, Dugosh KL, Mastro NK, Lee PA, DeMatteo DS, Patapis NS. Do research payments precipitate drug use or coerce participation? Drug Alcohol Depend 2005; 78(3):275-281.
14. Substance Abuse & Mental Health Services Administration. National Survey on Drug Use and Health, 2002. Rockville, MD, Substance Abuse & Mental Health Services Administration.
15. Cottler LB, Compton WM, Keating S. What incentives are effective rewards for 'hidden populations' interviewed as a part of research projects? Public Health Reports 1995; 110(2):178.
16. Shaner A, Eckman TA, Roberts LJ, Wilkins JN, Tucker DE, Tsuang JW, Mintz J. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers. A government-sponsored revolving door? New England Journal of Medicine 1995; 333:777-783.